NEW DRUG CANDIDATE TO BLOCK TUMOR STEM CELLS TUMOR STEM CELLS
An international consortium led by IRB Barcelona and the company Merus has discovered MCLA-158, an antibody that targets cancer stem cells in solid tumors and prevents metastasis in experimental models. The MCLA-158 antibody, commercially known as Petosemtamab, is a bispecific antibody that recognizes two distinct proteins on the surface of cancer stem cells, namely EGFR […]
NEW DRUG CANDIDATE TO BLOCK TUMOR STEM CELLS TUMOR STEM CELLS Read More »
